Cardiology

Top Story

Bivalirudin compares favorably to heparin, GPIs in patients with diabetes undergoing PCI

August 28, 2015

Treatment with bivalirudin yielded similar 30-day ischemic outcomes vs. heparin and glycoprotein inhibitors, with significantly lower rates of major and minor bleeding and 1-year mortality among patients with diabetes undergoing PCI, according to recent findings.

In a meta-analysis of randomized trials, researchers evaluated four randomized controlled trials comparing bivalirudin with unfractionated heparin and glycoprotein IIb/IIIa inhibitors (GPIs) in patients with diabetes undergoing PCI (n = 5,137). They assessed the incidence of major adverse cardiac events, all-cause mortality, MI, urgent revascularization and major and minor bleeding at 30 days, as well as all-cause mortality at 1 year.

In the Journals

CV events decreased in US since 2005; decline more pronounced in certain populations

August 28, 2015
Although major CV events and all-cause mortality rates in the United States decreased significantly between 2005 and 2011 among adults with diabetes, history of CVD or…
In the Journals

Five vital anticoagulation reads from the summer

August 28, 2015
Cardiology Today has compiled coverage of top anticoagulation research recently published in journals, offering clinicians an overview of where the field stands in using…
In the Journals

Atrial fibrillation/flutter rare, increases complication risk in pregnant women with heart disease

August 28, 2015
Atrial flutter or atrial fibrillation occurred infrequently in a large prospective registry of pregnant women with structural heart disease, but was associated with…
In the Journals

Thrombolysis system reduces artery pressure in intermediate-risk PE

August 28, 2015
Results of a real-world population study demonstrated the efficacy and safety of an ultrasound-assisted catheter-directed thrombolysis system for the treatment of…
More News Headlines »
CME
PCI in ACS: Deciding Among Clopidogrel, Prasugrel, or Ticagrelor

PCI in ACS: Deciding Among Clopidogrel, Prasugrel, or Ticagrelor

This activity is supported by an educational grant from Daiichi Sankyo, Inc. and Lilly USA, LLC

It is estimated that in the United States, each year, over 780,000 persons will experience an acute coronary syndrome…
More »
Video
VIDEO: Prenatal intervention may improve neurodevelopmental outcomes from congenital heart defects

VIDEO: Prenatal intervention may improve neurodevelopmental outcomes from congenital heart defects

July 23, 2015
PHILADELPHIA — In this video, J. William Gaynor, MD, a cardiac surgeon at the Children's Hospital of…
More »
CME
Cardiology Case Consults

The Patient with Obesity

No commercial support for this activity.

This CME activity will focus on the diagnosis and management of patients with obesity.
More »
morganatic-roan